ERBIN and cancer: Since we found that ERBIN plays a suppressive role in cancer development, pharmacologically targeting TGF‐β signaling in cancer cells may restore ERBIN expression and inhibit EMT induced by both TGF‐β stimulation and ERBIN downregulation.